Yüklüyor......
Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists
OBJECTIVE: To explore the implications of direct-to-consumer pharmacogenomic testing for community pharmacy practice. SUMMARY: In October 2018, the U.S. Food and Drug Administration provided approval for direct-to-consumer genetic testing company, 23andMe® (Mountain View, CA), to return select pharm...
Kaydedildi:
| Yayımlandı: | J Am Pharm Assoc (2003) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229642/ https://ncbi.nlm.nih.gov/pubmed/31327749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.japh.2019.06.008 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|